메뉴 건너뛰기




Volumn 4, Issue SUPPL. 2, 2011, Pages 12-15

Probiotic assisted colon targeted drug delivery system: Research scope

Author keywords

Colon specific drug delivery; Micro flora etc; Polysaccharides; Probiotics

Indexed keywords

POLYSACCHARIDE; PROBIOTIC AGENT;

EID: 83455266383     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (7)

References (32)
  • 3
    • 33947507370 scopus 로고    scopus 로고
    • Multiparticulate formulation approach to colon specific drug delivery: Current perspectives
    • Fatima LAA, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: Current perspectives. J Pharm Pharmaceut Sci 2006; 3:327-38.
    • (2006) J Pharm Pharmaceut Sci , vol.3 , pp. 327-338
    • Fatima, L.A.A.1    Chandran, S.2
  • 4
    • 0037139415 scopus 로고    scopus 로고
    • Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation
    • Libo Y, James SC, Joseph AF. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002; 235:1-15.
    • (2002) Int J Pharm , vol.235 , pp. 1-15
    • Libo, Y.1    James, S.C.2    Joseph, A.F.3
  • 6
    • 0038725720 scopus 로고    scopus 로고
    • Pharmaceutical approaches to colon targeted drug delivery systems
    • Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 2003; 6:33-66.
    • (2003) J Pharm Pharmaceut Sci , vol.6 , pp. 33-66
    • Chourasia, M.K.1    Jain, S.K.2
  • 10
    • 79951977317 scopus 로고    scopus 로고
    • Probiotic assisted colon specific delivery of diclofenac sodium from guar gum matrix tablet; in-vitro evaluation
    • Ghosh Prashant Kumar, Gupta Vipin Bihari, Gondoliya Bhavik, Probiotic assisted colon specific delivery of diclofenac sodium from guar gum matrix tablet; in-vitro evaluation. AJPS 2010, 173-178.
    • (2010) AJPS , pp. 173-178
    • Ghosh, P.K.1    Gupta, V.B.2    Gondoliya, B.3
  • 11
    • 0035859973 scopus 로고    scopus 로고
    • Polysaccharides in colon-specific drug delivery
    • Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001; 241:19-38.
    • (2001) Int J Pharm , vol.241 , pp. 19-38
    • Sinha, V.R.1    Kumria, R.2
  • 12
    • 83455242461 scopus 로고    scopus 로고
    • In Vitro Cytotoxicity Analysis of 5-Fluorouracil Loaded Guar Gum Microspheres on HT-29 Colon Cancer Cell Line
    • Kaushik Dinesh, Sardana Satish, Mishra D.N. In Vitro Cytotoxicity Analysis of 5-Fluorouracil Loaded Guar Gum Microspheres on HT-29 Colon Cancer Cell Line Int J Pharma 2009; 1(2): 83-84.
    • (2009) Int J Pharma , vol.1 , Issue.2 , pp. 83-84
    • Dinesh, K.1    Satish, S.2    Mishra, D.N.3
  • 13
    • 0025050623 scopus 로고
    • Microbially controlled drug delivery to the colon
    • Rubinstein A. Microbially controlled drug delivery to the colon. Bioph Drug Dispos 1990; 11:465-75.
    • (1990) Bioph Drug Dispos , vol.11 , pp. 465-475
    • Rubinstein, A.1
  • 14
    • 0034808152 scopus 로고    scopus 로고
    • The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides - a human volunteer study
    • Tuohy KM, Kolid S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides - a human volunteer study. Br J Nutr 2001; 86:341-8
    • (2001) Br J Nutr , vol.86 , pp. 341-348
    • Tuohy, K.M.1    Kolid, S.2    Lustenberger, A.M.3    Gibson, G.R.4
  • 15
    • 0031408739 scopus 로고    scopus 로고
    • Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis
    • Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997; 18:833-41.
    • (1997) Carcinogenesis , vol.18 , pp. 833-841
    • Singh, J.1    Rivenson, A.2    Tomita, M.3    Shimamura, S.4    Ishibashi, N.5    Reddy, B.S.6
  • 16
    • 83455256511 scopus 로고    scopus 로고
    • Development and in-vitro evalution of eudragit RS100 and insulin coated pectin matrix tablets of 5-fluorouracil for colon targeting
    • Gupta Sonia, Bedi PMS, Development and in-vitro evalution of eudragit RS100 and insulin coated pectin matrix tablets of 5-fluorouracil for colon targeting, IJAP, 2010.
    • (2010) IJAP
    • Sonia, G.1    Bedi, P.M.S.2
  • 17
    • 0041620130 scopus 로고    scopus 로고
    • In vivo pharmacokinetics in human volunteers: Oral administered guar gum-based colon-targeted 5-fluorouracil tablets
    • Krishnaiah Y.S.R, Satyanarayana S, In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets, Eur. J. Pharm. Sci 2003,19,355-362.
    • (2003) Eur. J. Pharm. Sci , vol.19 , pp. 355-362
    • Krishnaiah, Y.S.R.1    Satyanarayana, S.2
  • 18
    • 0035997045 scopus 로고    scopus 로고
    • In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil
    • Krishnaiah Y.S.R. Karthikeyan, R.S, Satyanarayana V, In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil, Eur. J. Pharm. Sci, 2002, 16, 185-192.
    • (2002) Eur. J. Pharm. Sci , vol.16 , pp. 185-192
    • Krishnaiah, Y.S.R.1    Karthikeyan, R.S.2    Satyanarayana, V.3
  • 20
    • 23444433790 scopus 로고    scopus 로고
    • Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets
    • Wilson PJ, Basit AW. Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets. Int J of Pharm 2005; 300:89-94.
    • (2005) Int J of Pharm , vol.300 , pp. 89-94
    • Wilson, P.J.1    Basit, A.W.2
  • 21
    • 33646943234 scopus 로고    scopus 로고
    • Colorectal Cancer After Start of Nonsteroidal Anti-Inflammatory Drug Use
    • Stürmer T, Buring J, Lee I, Kurth T, Gaziano J, Glynn R. Colorectal Cancer After Start of Nonsteroidal Anti-Inflammatory Drug Use. Am J Med 2006; 119:494-502.
    • (2006) Am J Med , vol.119 , pp. 494-502
    • Stürmer, T.1    Buring, J.2    Lee, I.3    Kurth, T.4    Gaziano, J.5    Glynn, R.6
  • 23
    • 0031006644 scopus 로고    scopus 로고
    • The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan
    • Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, et al. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res 1997; 57:1625-9.
    • (1997) Cancer Res , vol.57 , pp. 1625-1629
    • Seed, M.P.1    Brown, J.R.2    Freemantle, C.N.3    Papworth, J.L.4    Colville-Nash, P.R.5    Willis, D.6
  • 25
    • 0027389017 scopus 로고
    • Morphine-sparing effect of Diclofenac in cancer pain
    • Bjorkman R, Ullman A, Hedner J. Morphine-sparing effect of Diclofenac in cancer pain. Eur J Clin Pharmacol 1993; 44:1-5.
    • (1993) Eur J Clin Pharmacol , vol.44 , pp. 1-5
    • Bjorkman, R.1    Ullman, A.2    Hedner, J.3
  • 26
    • 0025050623 scopus 로고
    • Microbially controlled drug delivery to the colon
    • Rubinstein A. Microbially controlled drug delivery to the colon. Bioph Drug Dispos 1990; 11:465-75.
    • (1990) Bioph Drug Dispos , vol.11 , pp. 465-475
    • Rubinstein, A.1
  • 27
    • 11844253170 scopus 로고    scopus 로고
    • In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery
    • Sinha VR, Mittal BR, Kumria R. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm 2005; 289:79-85.
    • (2005) Int J Pharm , vol.289 , pp. 79-85
    • Sinha, V.R.1    Mittal, B.R.2    Kumria, R.3
  • 28
    • 0027476168 scopus 로고
    • In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier
    • Rubinstein A, Radai R, Ezra M, Pathak S, Rokem S. In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier. Pharm Res 1993;10:258-63
    • (1993) Pharm Res , vol.10 , pp. 258-263
    • Rubinstein, A.1    Radai, R.2    Ezra, M.3    Pathak, S.4    Rokem, S.5
  • 29
    • 78650259706 scopus 로고    scopus 로고
    • Effect of 5Fluorouracil Pretreatment on the In Vitro Drug Release from Colon-Targeted Guar Gum Matrix Tablets
    • Krishnaiah Y.S.R and Srinivas B.P, Effect of 5Fluorouracil Pretreatment on the In Vitro Drug Release from Colon-Targeted Guar Gum Matrix Tablets, The Open Drug Delivery Journal, 2008, 2, 71-76
    • (2008) The Open Drug Delivery Journal , vol.2 , pp. 71-76
    • Krishnaiah, Y.S.R.1    Srinivas, B.P.2
  • 31
    • 78650259706 scopus 로고    scopus 로고
    • Effect of 5Fluorouracil Pretreatment on the In Vitro Drug Release from Colon-Targeted Guar Gum Matrix Tablets
    • Krishnaiah Y.S.R and Srinivas B.P, Effect of 5Fluorouracil Pretreatment on the In Vitro Drug Release from Colon-Targeted Guar Gum Matrix Tablets, The Open Drug Delivery Journal, 2008, 2, 71-76
    • (2008) The Open Drug Delivery Journal , vol.2 , pp. 71-76
    • Krishnaiah, Y.S.R.1    Srinivas, B.P.2
  • 32
    • 0346787822 scopus 로고    scopus 로고
    • Colonic drug delivery of 5-fluorouracil: An in vitro evaluation
    • Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic drug delivery of 5-fluorouracil: An in vitro evaluation. Int J Pharm 2004; 269:101-8.
    • (2004) Int J Pharm , vol.269 , pp. 101-108
    • Sinha, V.R.1    Mittal, B.R.2    Bhutani, K.K.3    Kumria, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.